BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 8617698)

  • 1. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
    Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
    J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone as a treatment for Tourette's syndrome.
    Bruun RD; Budman CL
    J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
    Peterson BS
    J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
    Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
    J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder.
    Bruun RD
    Am J Psychiatry; 1988 May; 145(5):621-4. PubMed ID: 2895987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tourette syndrome: a follow-up study.
    Sandor P; Musisi S; Moldofsky H; Lang A
    J Clin Psychopharmacol; 1990 Jun; 10(3):197-9. PubMed ID: 2115892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of comorbidities of Tourette's syndrome and bipolar disorder in a 10-year-old boy.
    Wang PW; Huang MF; Yen CF; Huang RR
    Kaohsiung J Med Sci; 2009 Nov; 25(11):608-12. PubMed ID: 19858040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Tourette syndrome].
    Pushkov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(10):1476-9. PubMed ID: 2880439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tourette's syndrome: an expanded view.
    O'Quinn AN; Thompson RJ
    Pediatrics; 1980 Sep; 66(3):420-4. PubMed ID: 6932642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
    Sallee FR; Nesbitt L; Jackson C; Sine L; Sethuraman G
    Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysphoria associated with neuroleptic withdrawal in an adolescent with Tourette's disorder.
    Braña-Berríos M; Lam K; Coffey B
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):371-4. PubMed ID: 21851194
    [No Abstract]   [Full Text] [Related]  

  • 13. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH; Meador M; Fortune T; Llorena R
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR; Dougherty D; Sethuraman G; Vrindavanam N
    Biol Psychiatry; 1996 Nov; 40(10):1044-50. PubMed ID: 8915564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ; Sethi KD
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome.
    Silver AA; Shytle RD; Philipp MK; Sanberg PR
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1631-6. PubMed ID: 8973070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of Tourette's disorder: a literature review.
    Coffey BJ; Biederman J; Geller DA; Spencer T; Park KS; Shapiro SJ; Garfield SB
    Harv Rev Psychiatry; 2000 Oct; 8(4):192-8. PubMed ID: 11038344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder.
    Mikkelsen EJ; Detlor J; Cohen DJ
    Am J Psychiatry; 1981 Dec; 138(12):1572-6. PubMed ID: 6946714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.